Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients
Clinical Biochemistry, ISSN: 0009-9120, Vol: 33, Issue: 7, Page: 557-562
2000
- 21Citations
- 13Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations21
- Citation Indexes21
- 21
- CrossRef15
- Captures13
- Readers13
- 13
Article Description
Objectives: Tacrolimus is an immunosuppressant drug with a narrow therapeutic window and thus requires therapeutic drug monitoring. This study evaluates the suitability of the second-generation microparticle enzyme immunoassay (MEIA II) against a specific method, high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS), for the measurement of tacrolimus in both heart- and lung-transplant groups. A secondary objective was to investigate the effect of tacrolimus concentration on MEIA II measurement.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0009912000001636; http://dx.doi.org/10.1016/s0009-9120(00)00163-6; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0034537458&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/11124341; http://linkinghub.elsevier.com/retrieve/pii/S0009912000001636; http://api.elsevier.com/content/article/PII:S0009912000001636?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0009912000001636?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0009912000001636; http://dx.doi.org/10.1016/s0009-9120%2800%2900163-6; https://dx.doi.org/10.1016/s0009-9120%2800%2900163-6
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know